Functionalized congeners of 1,4-dihydropyridines as antagonist molecular probes for A3 adenosine receptors

Bioconjugate Chemistry

Volumn 10, Issue 4, 1999, Pages 667-677

  Li, An Hu ^a   Chang, Louis ^a   Ji, Xiao Duo ^a   Melman, Neli ^a   Jacobson, Kenneth A ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDROPYRIDINE; 4 PHENYLETHYNYL 6 PHENYL 1,4 DIHYDROPYRIDINE; ADENOSINE; CONGENER; MEMBRANE RECEPTOR; MOLECULAR AND CELLULAR STRUCTURE;

BINDING SITES; CHAINS; CLONING; ESTERS; FLUORINE COMPOUNDS; PROBES;

ADENOSINE RECEPTOR; BENZYL ESTERS; BINDING ASSAYS; DIHYDROPYRIDINES; ESTER GROUPS; FUNCTIONALIZED; MOLECULAR PROBES; PHENYLETHYNYL; RADIOLIGAND BINDING; RATS BRAIN;

PYRIDINE;

EID: 0033167127     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc9900136     Document Type: Article

References (36)

1. Jacobson, K. A., and Suzuki, F. (1997) Recent developments in selective agonists and antagonists acting at purine and pyrimidine receptors. Drug Dev. Res. 39, 289-300.
2. 3 adenosine receptor. Proc. Natl. Acad. Sci. U.S.A. 89, 7432-7436.
3. 3 adenosine receptor. Proc. Natl. Acad. Sci. U.S.A. 90, 10365-10369.
4. 3 adenosine receptors: Novel ligands and paradoxical effects. Trends Pharmacol. Sci. 19, 184-191.
5. 3 receptor stimulation and cerebral ischemia. Eur. J. Pharmacol. 263, 59-67.
6. 3 receptor agonist and cerebral ischemia: neuronal and glial effects. Eur. J. Pharmacol. 367, 157-163.
7. 3 receptors. J. Clin. Invest. 98, 1773-1779.
8. 3 receptors during prolonged stimulated ischemia. Am. J. Physiol. 273, H501-H505.
9. 3 receptor agonists. Biochem. Biophys. Res. Commun. 219, 904-910.
10. 3 adenosine receptors agonist. Exp. Cell Res. 243, 383-397.
11. Karton, Y., Jiang, J. L., Ji, X. D., Melman, N., Olah, M. E., Stiles, G. L., and Jacobson, K. A. (1996) Synthesis and biological-activities of flavonoid derivatives as as adenosine receptor antagonists. J. Med. Chem. 39, 2293-2301.
12. 3 adenosine receptor antagonists. J. Med. Chem. 40, 2596-2608.
13. 3 adenosine receptor antagonists. Drug Dev. Res. 37, 131.
14. 3 adenosine receptor antagonists. J. Med. Chem. 41, 3186-3201.
15. 3 receptor ligands. II. Structure affinity profile of a series of isoquinoline and quinazolinecompounds. J. Med. Chem. 41, 3994-4000.
16. 3 receptor subtype. J. Med. Chem. 39, 4142-4148.
17. 3 receptors in mast-cells. Trends Pharmacol. Sci. 15, 13-14.
18. 3 adenosine receptors and ischemic brain injury: a hope or a disaster? Drug Dev. Res. 37, 140.
19. Stout, D. M., and Myers, A. I. (1982) Recent advances in the chemistry of dihydropyridines. Chem. Rev. 82, 223-243.
20. Goldmann, S., and Stoltefuss, J. (1991) 1,4-Dihydropyridines: Effect of chirality and conformation on the calcium antagonist and calcium agonist activities. Angew. Chem., Int. Ed. Engl. 1559-1578.
21. Jacobson, K. A. (1990) Molecular probes for adenosine receptors. In Purines in Cellular Signaling: Targets for New Drugs (K. A. Jacobson, J. W. Daly, and V. Manganiello, Eds.) pp 54-64, Springer, New York.
22. 6-phenylisopropyladenosine. Naunyn-Schmiedeberg's Arch. Pharmacol. 313, 179-187.
23. 2 receptors in rat brain tissue. J. Pharmacol. Exp. Ther. 251, 888-893.
24. 3 adenosine receptor. Mol. Pharmacol. 45, 978-982.
25. 50) of an enzyme reaction. Biochem. Pharmacol. 22, 3099-3108.
26. 1-adenosine receptors. Bioconjugate Chem. 6, 255-263.
27. 2 adenosine receptors. Naunyn-Schmeideberg's Arch. Pharamacol. 347, 521-526.
28. 2-adenosine receptors. Drug Dev. Res. 29, 292-298.
29. Morey, T. E., Belardinelli, L., and Dennis, D. M. (1998) Validation of Furchgott's method to determine agonist-dependent A1-adenosine receptor reserve in guinea-pig atrium. Br. J. Pharmacol 7, 1425-1433.
30. 3 adenosine receptors. Biochem. Biophys. Res. Commun. 203, 570-576.
31. 1-adenosine in guinea pig atrioventricular node. Am. J. Physiol. 262, H661-H671.
32. 1 MF-2 cells and heart. Mol. Pharmacol. 52, 491-498.
33. 2A-adenosine receptor reserve for coronary vasodilation. Circulation 7, 711-718.
34. Jacobson, K. A., Kirk, K. L., Padgett, W. L., and Daly, J. W. (1985) Functionalized congeners of 1,3-dialkylxanthines: preparation of analogues with high affinity for adenosine receptors. J. Med. Chem. 28, 1334-1340.
35. 1-antagonist telenzepine. Bioconjugate Chem. 3, 234-240.
36. 2Y-purinoceptor agonists: Structure activity relationships for 2-thioether derivatives of adenosine-5′-triphosphate. J. Med. Chem. 36, 3937-3946.